These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

369 related items for PubMed ID: 20087367

  • 1. Xenon is an inhibitor of tissue-plasminogen activator: adverse and beneficial effects in a rat model of thromboembolic stroke.
    David HN, Haelewyn B, Risso JJ, Colloc'h N, Abraini JH.
    J Cereb Blood Flow Metab; 2010 Apr; 30(4):718-28. PubMed ID: 20087367
    [Abstract] [Full Text] [Related]

  • 2. Interactions between nitrous oxide and tissue plasminogen activator in a rat model of thromboembolic stroke.
    Haelewyn B, David HN, Colloc'h N, Colomb DG, Risso JJ, Abraini JH.
    Anesthesiology; 2011 Nov; 115(5):1044-53. PubMed ID: 21952256
    [Abstract] [Full Text] [Related]

  • 3. Modulation by the Noble Gas Helium of Tissue Plasminogen Activator: Effects in a Rat Model of Thromboembolic Stroke.
    Haelewyn B, David HN, Blatteau JE, Vallée N, Meckler C, Risso JJ, Abraini JH.
    Crit Care Med; 2016 Jun; 44(6):e383-9. PubMed ID: 26646461
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Adjuvant treatment with neuroserpin increases the therapeutic window for tissue-type plasminogen activator administration in a rat model of embolic stroke.
    Zhang Z, Zhang L, Yepes M, Jiang Q, Li Q, Arniego P, Coleman TA, Lawrence DA, Chopp M.
    Circulation; 2002 Aug 06; 106(6):740-5. PubMed ID: 12163437
    [Abstract] [Full Text] [Related]

  • 6. Effects of tissue plasminogen activator timing on blood-brain barrier permeability and hemorrhagic transformation in rats with transient ischemic stroke.
    Zhang Y, Wang Y, Zuo Z, Wang Z, Roy J, Hou Q, Tong E, Hoffmann A, Sperberg E, Bredno J, Berr SS, Xie M, Lee K, Wintermark M.
    J Neurol Sci; 2014 Dec 15; 347(1-2):148-54. PubMed ID: 25292413
    [Abstract] [Full Text] [Related]

  • 7. Activated protein C analog protects from ischemic stroke and extends the therapeutic window of tissue-type plasminogen activator in aged female mice and hypertensive rats.
    Wang Y, Zhao Z, Chow N, Rajput PS, Griffin JH, Lyden PD, Zlokovic BV.
    Stroke; 2013 Dec 15; 44(12):3529-36. PubMed ID: 24159062
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Normobaric hyperoxia reduces the neurovascular complications associated with delayed tissue plasminogen activator treatment in a rat model of focal cerebral ischemia.
    Liu W, Hendren J, Qin XJ, Liu KJ.
    Stroke; 2009 Jul 15; 40(7):2526-31. PubMed ID: 19478225
    [Abstract] [Full Text] [Related]

  • 10. Mast cell stabilization reduces hemorrhage formation and mortality after administration of thrombolytics in experimental ischemic stroke.
    Strbian D, Karjalainen-Lindsberg ML, Kovanen PT, Tatlisumak T, Lindsberg PJ.
    Circulation; 2007 Jul 24; 116(4):411-8. PubMed ID: 17606844
    [Abstract] [Full Text] [Related]

  • 11. Taurine Reduces tPA (Tissue-Type Plasminogen Activator)-Induced Hemorrhage and Microvascular Thrombosis After Embolic Stroke in Rat.
    Jin R, Xiao AY, Liu S, Wang M, Li G.
    Stroke; 2018 Jul 24; 49(7):1708-1718. PubMed ID: 29844028
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of tPA-induced hemorrhagic transformation involves adenosine A2b receptor activation after cerebral ischemia.
    Li Q, Han X, Lan X, Hong X, Li Q, Gao Y, Luo T, Yang Q, Koehler RC, Zhai Y, Zhou J, Wang J.
    Neurobiol Dis; 2017 Dec 24; 108():173-182. PubMed ID: 28830843
    [Abstract] [Full Text] [Related]

  • 13. Therapeutic benefits of combined treatment with tissue plasminogen activator and 2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxy-β-d-pyranoside in an animal model of ischemic stroke.
    Yu S, Liu X, Shen Y, Xu H, Yang Y, Ding F.
    Neuroscience; 2016 Jul 07; 327():44-52. PubMed ID: 27060484
    [Abstract] [Full Text] [Related]

  • 14. IMM-H004 prevents toxicity induced by delayed treatment of tPA in a rat model of focal cerebral ischemia involving PKA-and PI3K-dependent Akt activation.
    Zuo W, Chen J, Zhang S, Tang J, Liu H, Zhang D, Chen N.
    Eur J Neurosci; 2014 Jun 07; 39(12):2107-18. PubMed ID: 24649933
    [Abstract] [Full Text] [Related]

  • 15. Plasmin-dependent modulation of the blood-brain barrier: a major consideration during tPA-induced thrombolysis?
    Niego B, Medcalf RL.
    J Cereb Blood Flow Metab; 2014 Aug 07; 34(8):1283-96. PubMed ID: 24896566
    [Abstract] [Full Text] [Related]

  • 16. Phosphorylated recombinant HSP27 protects the brain and attenuates blood-brain barrier disruption following stroke in mice receiving intravenous tissue-plasminogen activator.
    Shimada Y, Shimura H, Tanaka R, Yamashiro K, Koike M, Uchiyama Y, Urabe T, Hattori N.
    PLoS One; 2018 Aug 07; 13(5):e0198039. PubMed ID: 29795667
    [Abstract] [Full Text] [Related]

  • 17. Hydrogen Sulfide Attenuates Tissue Plasminogen Activator-Induced Cerebral Hemorrhage Following Experimental Stroke.
    Liu H, Wang Y, Xiao Y, Hua Z, Cheng J, Jia J.
    Transl Stroke Res; 2016 Jun 07; 7(3):209-19. PubMed ID: 27018013
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Whole body hypothermia extends tissue plasminogen activator treatment window in the rat model of embolic stroke.
    Hassanipour M, Zarisfi M, Ehsani V, Allahtavakoli M.
    Life Sci; 2020 Sep 01; 256():117450. PubMed ID: 32087233
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.